Creutzfeldt‐Jakob disease with neuroleptic malignant syndrome | Zendy

Čiauškaitė Julija | Zendy; Puleikytė Ieva | Zendy; Jesmanas Simonas | Zendy; Jurkevičienė Giedrė | Zendy; Vaitkus Antanas | Zendy; Rastenytė Daiva | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Creutzfeldt‐Jakob disease with neuroleptic malignant syndrome

Author(s) -

Čiauškaitė Julija,

Puleikytė Ieva,

Jesmanas Simonas,

Jurkevičienė Giedrė,

Vaitkus Antanas,

Rastenytė Daiva

Publication year - 2021

Publication title -

clinical case reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.21

H-Index - 9

ISSN - 2050-0904

DOI - 10.1002/ccr3.4699

Subject(s) - neuroleptic malignant syndrome , medicine , quetiapine , disease , complication , pediatrics , antipsychotic , creutzfeldt jakob syndrome , psychiatry , schizophrenia (object oriented programming) , pathology , surgery , prion protein

Creutzfeldt‐Jakob disease (CJD) is a rare rapidly progressive fatal neurodegenerative disease. Neuroleptic malignant syndrome (NMS) is a complication of antipsychotic medications which may be used to treat neuropsychiatric symptoms of CJD. We present a case of a 51‐year‐ old woman with CJD who developed NMS after being prescribed quetiapine.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research